| SpectraBase Spectrum ID |
8H8Uh35MqoK |
| Name |
N-(2-Fluorobenzyl)-2,3-MDMA |
| Classification |
Amphetamine designer drug derivative |
| Copyright |
Copyright © 2024-2025 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
301.147807049 u |
| Formula |
C18H20FNO2 |
| InChI |
InChI=1S/C18H20FNO2/c1-13(20(2)11-15-6-3-4-8-16(15)19)10-14-7-5-9-17-18(14)22-12-21-17/h3-9,13H,10-12H2,1-2H3 |
| InChIKey |
CPVGOUDCWWYRKN-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
301.361 g/mol |
| Nominal Mass |
301 u |
| Quality |
996 |
| Retention Index |
2251 |
| SMILES |
C=12C(CC(N(CC=3C(=CC=CC3)F)C)C)=CC=CC1OCO2 |
| SPLASH |
splash10-0a4i-2900000000-82b07388854166a838f8 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
2,3-MDMA,N-(2-Fluorobenzyl)-
1-(1,3-benzodioxol-4-yl)-N-(2-fluorobenzyl)-N-methylpropan-2-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_013444 |
